These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 32839279)

  • 21. The prevalence of chronic kidney disease in the general population in Romania: a study on 60,000 persons.
    Cepoi V; Onofriescu M; Segall L; Covic A
    Int Urol Nephrol; 2012 Feb; 44(1):213-20. PubMed ID: 21360160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and early detection of chronic kidney disease at primary healthcare.
    Nagib SN; Abdelwahab S; Amin GEE; Allam MF
    Clin Exp Hypertens; 2021 Jul; 43(5):416-418. PubMed ID: 33726610
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of serum electrolytes and kidney function test for screening of chronic kidney disease among Ethiopian Public Health Institute staff members, Addis Ababa, Ethiopia.
    Molla MD; Degef M; Bekele A; Geto Z; Challa F; Lejisa T; Getahun T; Sileshi M; Tolcha Y; Ashebir G; Seifu D
    BMC Nephrol; 2020 Nov; 21(1):494. PubMed ID: 33208123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The burden of unrecognised chronic kidney disease in patients with type 2 diabetes at a county hospital clinic in Kenya: implications to care and need for screening.
    Otieno FCF; Ogola EN; Kimando MW; Mutai K
    BMC Nephrol; 2020 Feb; 21(1):73. PubMed ID: 32111192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Kidney Disease among Middle-Aged and Elderly Population: A cross-sectional screening in a Hospital Camp in Varanasi, India.
    Rai PK; Rai P; Bhat RG; Bedi S
    Saudi J Kidney Dis Transpl; 2019; 30(4):795-802. PubMed ID: 31464235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-effectiveness of using chronic kidney disease risk scores to screen for early-stage chronic kidney disease.
    Yarnoff BO; Hoerger TJ; Simpson SK; Leib A; Burrows NR; Shrestha SS; Pavkov ME;
    BMC Nephrol; 2017 Mar; 18(1):85. PubMed ID: 28288579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns and Predictors of Screening for Breast and Cervical Cancer in Women with CKD.
    Wong G; Hayward JS; McArthur E; Craig JC; Nash DM; Dixon SN; Zimmerman D; Kitchlu A; Garg AX
    Clin J Am Soc Nephrol; 2017 Jan; 12(1):95-104. PubMed ID: 28034851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The See Kidney Disease Targeted Screening Program for CKD.
    Galbraith LE; Ronksley PE; Barnieh LJ; Kappel J; Manns BJ; Samuel SM; Jun M; Weaver R; Valk N; Hemmelgarn BR
    Clin J Am Soc Nephrol; 2016 Jun; 11(6):964-972. PubMed ID: 27197905
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities.
    Hustrini NM
    Acta Med Indones; 2023 Jan; 55(1):1-3. PubMed ID: 36999266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Population-Based Analysis of Quality Indicators in CKD.
    Manns L; Scott-Douglas N; Tonelli M; Weaver R; Tam-Tham H; Chong C; Hemmelgarn B
    Clin J Am Soc Nephrol; 2017 May; 12(5):727-733. PubMed ID: 28377473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic kidney disease epidemic: How do we deal with it?
    Ng JK; Li PK
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():116-120. PubMed ID: 30298662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiplatelet agents for chronic kidney disease.
    Natale P; Palmer SC; Saglimbene VM; Ruospo M; Razavian M; Craig JC; Jardine MJ; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2022 Feb; 2(2):CD008834. PubMed ID: 35224730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Income Level and Impaired Kidney Function Among Working Adults in Japan.
    Ishimura N; Inoue K; Maruyama S; Nakamura S; Kondo N
    JAMA Health Forum; 2024 Mar; 5(3):e235445. PubMed ID: 38427342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic kidney disease management program in Shahreza, Iran.
    Barahimi H; Aghighi M; Aghayani K; Rahimi Foroushani A
    Iran J Kidney Dis; 2014 Nov; 8(6):450-6. PubMed ID: 25362219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention.
    Lamprea-Montealegre JA; Shlipak MG; Estrella MM
    Heart; 2021 Aug; 107(16):1282-1288. PubMed ID: 33568433
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of chronic kidney disease in the community using data from OxRen: a UK population-based cohort study.
    Hirst JA; Hill N; O'Callaghan CA; Lasserson D; McManus RJ; Ogburn E; Mena JMO; Shine B; Taylor CJ; Vazquez-Montes MD; Yang Y; Hobbs FR
    Br J Gen Pract; 2020 Apr; 70(693):e285-e293. PubMed ID: 32041766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic kidney disease and kidney health care status: the healthy life in Suriname (HeliSur) study.
    Nannan Panday R; Haan Y; Diemer F; Punwasi A; Rommy C; Heerenveen I; van Montfrans GA; Brewster LM
    Intern Emerg Med; 2019 Mar; 14(2):249-258. PubMed ID: 30361850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum Albumin and High-Sensitivity C-reactive Protein are Independent Risk Factors of Chronic Kidney Disease in Middle-Aged Japanese Individuals: the Circulatory Risk in Communities Study.
    Kubo S; Kitamura A; Imano H; Cui R; Yamagishi K; Umesawa M; Muraki I; Kiyama M; Okada T; Iso H;
    J Atheroscler Thromb; 2016 Sep; 23(9):1089-98. PubMed ID: 26911856
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.